Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-27 @ 11:23 PM
Study NCT ID:
NCT01278160
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2011-01-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Comparison of Biphasic Insulin Aspart 30 Twice Daily With Two Different Initial Dosage Split Regimens in Subjects With Type 2 Diabetes: An Extension to Trial BIASP-3756
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01
Start Date Type:
None
Primary Completion Date:
2011-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-09
Completion Date Type:
ACTUAL
First Submit Date:
2011-01-14
First Submit QC Date:
None
Study First Post Date:
2011-01-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-09-14
Results First Submit QC Date:
None
Results First Post Date:
2012-10-18
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-16
Last Update Post Date:
2014-10-27
Last Update Post Date Type:
ESTIMATED